Daily Mail

NHS patients may be denied new prostate cancer drug
Best Medical Cover
The National Institute for Health and Clinical Excellence (NICE) says that abiraterone in combination with prednisone or prednisolone is not recommended for men with prostate cancer that has spread following chemotherapy and cannot be operated upon.
Zytiga cost too high, says NICEInPharm
NICE draft "no" for ZytigaPharma Times
Charities condemn 'no' decision on prostate drugOnMedica
Netdoctor -Telegraph.co.uk (blog) -WebMD.Boots.com
all 281 news articles »